Cover Image
Market Research Report
Product code

Global Active Pharmaceutical Ingredients Market, Size, Share, Opportunities and Forecast, 2020-2027

Published: | DataM Intelligence | 180 Pages | Delivery time: 2 business days


Back to Top
Global Active Pharmaceutical Ingredients Market, Size, Share, Opportunities and Forecast, 2020-2027
Published: April 3, 2021
DataM Intelligence
Content info: 180 Pages
Delivery time: 2 business days
  • ALL
  • Description
  • Table of Contents

Global Active Pharmaceutical Ingredient/ API Market is segmented By Type (Synthetic API, Biotech API), By Nature (Generic API, Innovator API), By Manufacturing type (Captive, Merchant), By Application (Cardiovascular, Diabetes, Oncology, Orthopaedics, Neurology, NSAIDS, Others), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Share, Size, Outlook, and Opportunity Analysis, 2020-2027

Market Overview

The Active Pharmaceutical Ingredients Market forecast for the year 2026 is expected to grow with a CAGR of 4.7% during the period (2020-2027).

Market Segmentation

By type, the market is divided into Synthetic API and Biotech API.

Biotech APIs include Monoclonal Antibodies, Purified Proteins, Recombinant Proteins, Recombinant Hormones, Synthetic Immunomodulators, Vaccines, Recombinant Enzymes, Antibiotics, Statins, and Others.

By manufacturing type, the market is divided into Captive and Merchant.

Captive API is the largest segment covering a significant part of the global API market with a market share of approximately 61% while the remaining is taken by Merchant API.

By End User, the market is classified into-Patients with chronical diseases, Physicians, Hetero Labs, Pharmaceutical companies, Hospitals, Parents/Relatives, and Others.

Based on Nature into Generic API and Innovator API.

Based on Application as Cardiovascular, Diabetes, Oncology, Orthopaedics, Neurology, NSAIDS, and Others.

Market Dynamics

Aurobindo Pharma has the highest Active Pharmaceutical Ingredients Market Share.

Patent expiration of a drug leads to its generic version and the manufacturers bear the cost.

This decreases the overall cost of the ingredient thereby increasing the number of users, which further increases the global market for the parts.

For instance, the patent for Teva's long-acting MS med Copaxone 40 mg, which has a revenue of 3.48 billion in the U.S. expired allowing the manufacturers to use the technology and produce the drug leading to an increase in production from 80% to 85%.

Patent expiries of the branded drugs, increased uptake of biologics, government initiatives for biomedical research are majorly driving the global Active Pharmaceutical Ingredients Market. However, Unfavourable Drug Price Control Policies across Various Countries is holding back the growth of the market.

Geographical Analysis

The report segments the geographies by region, which include North America, South America, Europe, Asia Pacific, and RoW.

North America dominates the Global Active Pharmaceutical Ingredients Market with a share of approximately 40.1%, followed by Europe with 24%.

Increasing medical requirements, advancement in R&D and innovations in this regions are favoring the growth of the market.

The scope of the report

This Active Pharmaceutical Ingredients Report covers factors impacting the market, Porter 5 Forces, Market Share Analysis, Price trend analysis, Product Benchmarking, and Company Profiles.

This report covers end-user market size, share and forecast analysis.

The report profiles various companies including Aurobindo Pharma, Mylan, Teva Active Pharmaceutical Ingredients, Ipca, Hetero Labs, Pharmaceutical companies Aceto Corporation, Arevipharma GmbH, Dr. Reddy's Laboratories, Pfizer, Inc, Novartis International AG, Sanofi, Ranbaxy, and Sun Pharma.

Why purchase the Active Pharmaceutical Ingredients Report?

Visualization of Active Pharmaceutical Ingredients Market composition across each indication, regarding type and applications, highlighting the critical commercial assets and players.

Identification of commercial opportunities in Active Pharmaceutical Ingredients by analyzing trends and co-development deals.

Excel data sheet with thousands of data points of market level 4/5 segmentation

PDF report with the most relevant analysis cogently put together after exhaustive qualitative interviews and in-depth market study

Product mapping in excel for crucial products of all major market players

Related Reports

Pharmaceutical Logistics Market

Radiopharmaceuticals Market

Table of Contents

Table of Contents

Table of Content

1. Active Pharmaceutical Ingredients Market - Methodology and Scope

  • 1.1. Research methodology
  • 1.2. Scope of the Report

2. Active Pharmaceutical Ingredients Market - Trends

  • 2.1. Key Trends & Developments

3. Active Pharmaceutical Ingredients Market - Industry Analysis

  • 3.1. Industry Impact Factors (Drivers & Restraints)
  • 3.2. Competitive Intensity- Porter 5 Forces
  • 3.3. Regulatory Analysis

4. Active Pharmaceutical Ingredients Market Analysis

  • 4.1. By Type
    • 4.1.1. Synthetic API
    • 4.1.2. Biotech API
  • 4.2. By Nature
    • 4.2.1. Generic API
    • 4.2.2. Innovator API
  • 4.3. By Manufacturing type
    • 4.3.1. Captive
    • 4.3.2. Merchant
  • 4.4. By Application
    • 4.4.1. Cardiovascular
    • 4.4.2. Diabetes
    • 4.4.3. Oncology
    • 4.4.4. Orthopaedics
    • 4.4.5. Neurology
    • 4.4.6. NSAIDS
    • 4.4.7. Others

5. Active Pharmaceutical Ingredients Market - Geographical Analysis

  • 5.1. North America
    • 5.1.1. The USA
    • 5.1.2. Canada
    • 5.1.3. Mexico
  • 5.2. Europe
    • 5.2.1. Germany
    • 5.2.2. France
    • 5.2.3. The UK
    • 5.2.4. Italy
    • 5.2.5. Spain
    • 5.2.6. Rest of Europe
  • 5.3. Asia Pacific
    • 5.3.1. China
    • 5.3.2. Japan
    • 5.3.3. India
    • 5.3.4. Australia
    • 5.3.5. Rest of Asia Pacific
  • 5.4. South America
    • 5.4.1. Brazil
    • 5.4.2. Argentina
    • 5.4.3. Rest of South America
  • 5.5. RoW

6. Active Pharmaceutical Ingredients Market - Competitive Landscape

  • 6.1. Market Share Analysis
  • 6.2. Key Strategies
  • 6.3. Product Benchmarking

7. Active Pharmaceutical Ingredients Market - Company Profiles

  • 7.1. Aurobindo Pharma
  • 7.2. Mylan
  • 7.3. Teva Active Pharmaceutical Ingredients
  • 7.4. Ipca
  • 7.5. Aceto Corporation
  • 7.6. Arevipharma GmbH
  • 7.7. Dr. Reddy’s
  • 7.8. Pfizer, Inc
  • 7.9. Novartis International AG
  • 7.10. Sanofi
  • 7.11. Ranbaxy
  • 7.12. Sun Pharma

8. Active Pharmaceutical Ingredients Market - Appendix

  • 8.1. Sources
  • 8.2. List of Tables
  • 8.3. Expert Panel Validation
  • 8.4. Disclaimer
  • 8.5. Contact Us